Type 2 diabetes and metabolic syndrome are associated with increased expression of 11beta-hydroxysteroid dehydrogenase 1 in obese subjects

被引：0
|
作者：
Luisella, Alberti
Girola, Andrea
Gilardini, Luisa
Conti, Antonio
Micheletto, Giancarlo
Invitti, Cecilia
机构：
[1] Inst Auxol Italiano, Milan, Italy
[2] Univ Milan, Milan, Italy
来源：
INTERNATIONAL JOURNAL OF OBESITY | 2007年 / 31卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S88 / S88
页数：1
相关论文
共 50 条
  • [31] The physiologic significance of 11beta-hydroxysteroid dehydrogenase type 1 in fetal lung development redux
    Torday, JS
    HORMONE AND METABOLIC RESEARCH, 2005, 37 (01) : 56 - 57
  • [32] The role and regulation of 11 beta-hydroxysteroid dehydrogenase type 1 in obesity and the metabolic syndrome
    Stimson, Roland H.
    Walker, Brian R.
    HORMONE MOLECULAR BIOLOGY AND CLINICAL INVESTIGATION, 2013, 15 (02) : 37 - 48
  • [33] Expression of 11beta-hydroxysteroid dehydrogenase 2 contributes to glucocorticoid resistance in lymphoblastic leukemia cells
    Sai, Shuji
    Nakagawa, Yuichi
    Yamaguchi, Rie
    Suzuki, Masako
    Sakaguchi, Kimiyoshi
    Okada, Shuichi
    Seckl, Jonathan R.
    Ohzeki, Takehiko
    Chapman, Karen E.
    LEUKEMIA RESEARCH, 2011, 35 (12) : 1644 - 1648
  • [34] Hepatic mRNA expression of 11beta-hydroxysteroid dehydrogenase type 1 (11beta-HSD1) in patients with non-alcoholic steatohepatitis (NASH)
    Konopelska, S.
    Kienitz, T.
    Pirlich, M.
    Bauditz, J.
    Stewart, P. M.
    Lochs, H.
    Strasburger, C. J.
    Quinkler, M.
    EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 2007, 115 : S48 - S48
  • [35] A novel genetically-obese rat model with elevated 11beta-hydroxysteroid dehydrogenase type 1 activity in subcutaneous adipose tissue
    Prasad, Sakamuri S. S. Vara
    Prashanth, Anamthathmakula
    Kumar, Chodavarapu Pavan
    Reddy, Sirisha J.
    Giridharan, Nappan V.
    Vajreswari, Ayyalasomayajula
    LIPIDS IN HEALTH AND DISEASE, 2010, 9
  • [36] A novel genetically-obese rat model with elevated 11beta-hydroxysteroid dehydrogenase type 1 activity in subcutaneous adipose tissue
    Sakamuri SS Vara Prasad
    Anamthathmakula Prashanth
    Chodavarapu Pavan Kumar
    Sirisha J Reddy
    Nappan V Giridharan
    Ayyalasomayajula Vajreswari
    Lipids in Health and Disease, 9
  • [37] Inhibitors of 11β-hydroxysteroid dehydrogenase type 1 for the treatment of metabolic syndrome
    Wang, MH
    CURRENT OPINION IN INVESTIGATIONAL DRUGS, 2006, 7 (04) : 319 - 323
  • [38] 11β-hydroxysteroid dehydrogenase type 1 activity in lean and obese males with type 2 diabetes mellitus
    Valsamakis, G
    Anwar, A
    Tomlinson, JW
    Shackleton, CHL
    McTernan, PG
    Chetty, R
    Wood, PJ
    Banerjee, AK
    Holder, G
    Barnett, AH
    Stewart, PM
    Kumar, S
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2004, 89 (09): : 4755 - 4761
  • [39] Polymorphisms in the promoter of the human 11beta-hydroxysteroid dehydrogenase type 2 (11B-HSD2) gene
    Alikhani-Koupaei, R.
    Fouladkou, F.
    Fustier, F.
    Cenni, B.
    Sharma, A. M.
    Deter, H. C.
    Frey, B. M.
    Frey, F. J.
    CLINICAL BIOCHEMISTRY, 2008, 41 (03) : 186 - 186
  • [40] SERUM CORTISONE AND CORTISOL/CORTISONE RATIO AS TOOL TO IDENTIFY SUBJECTS WITH SEVERE AND PARTIAL 11BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 2 DEFICIENCIES
    Carvajal, Cristian
    Tapia-Castillo, Alejandra
    Martinez-Aguayo, Alejandro
    Valdivia, Carolina
    Campino, Carmen
    Baudrand, Rene
    Allende, Fidel
    Pinochet, Constanza
    Iturrieta, Virginia
    Lizama, Jaime
    Solari, Sandra
    Fardella, Carlos
    JOURNAL OF HYPERTENSION, 2016, 34 : E329 - E329
12345